Scimago Journal & Country Rank

Expert Review of Precision Medicine and Drug Development

Country

United Kingdom

Universities and research institutions in United Kingdom
Media Ranking in United Kingdom

Subject Area and Category

Publisher

Taylor and Francis Ltd.

H-Index

16

Publication type

Journals

ISSN

23808993

Coverage

2016-2023

Information

Homepage

How to publish in this journal

Scope

Expert Review of Precision Medicine and Drug Development publishes primarily review articles covering the development and clinical application of medicine to be used in a personalized therapy setting; in addition, the journal also publishes original research and commentary-style articles. In an era where medicine is recognizing that a one-size-fits-all approach is not always appropriate, it has become necessary to identify patients responsive to treatments and treat patient populations using a tailored approach. Areas covered include: Development and application of drugs targeted to specific genotypes and populations, as well as advanced diagnostic technologies and significant biomarkers that aid in this. Clinical trials and case studies within personalized therapy and drug development. Screening, prediction and prevention of disease, prediction of adverse events, treatment monitoring, effects of metabolomics and microbiomics on treatment. Secondary population research, genome-wide association studies, disease–gene association studies, personal genome technologies. Ethical and cost–benefit issues, the impact to healthcare and business infrastructure, and regulatory issues. Join the conversation about this journal
Quartiles

The set of journals have been ranked according to their SJR and divided into four equal groups, four quartiles. Q1 (green) comprises the quarter of the journals with the highest values, Q2 (yellow) the second highest values, Q3 (orange) the third highest values and Q4 (red) the lowest values.

CategoryYearQuartile
Drug Discovery2018Q3
Drug Discovery2019Q2
Drug Discovery2020Q3
Drug Discovery2021Q3
Drug Discovery2022Q3
Drug Discovery2023Q4
Genetics2018Q4
Genetics2019Q3
Genetics2020Q4
Genetics2021Q4
Genetics2022Q4
Genetics2023Q4
Molecular Medicine2018Q4
Molecular Medicine2019Q3
Molecular Medicine2020Q4
Molecular Medicine2021Q4
Molecular Medicine2022Q4
Molecular Medicine2023Q4
Pharmacology2018Q3
Pharmacology2019Q3
Pharmacology2020Q3
Pharmacology2021Q3
Pharmacology2022Q3
Pharmacology2023Q3
SJR

The SJR is a size-independent prestige indicator that ranks journals by their 'average prestige per article'. It is based on the idea that 'all citations are not created equal'. SJR is a measure of scientific influence of journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from It measures the scientific influence of the average article in a journal, it expresses how central to the global scientific discussion an average article of the journal is.

YearSJR
20180.355
20190.511
20200.387
20210.329
20220.317
20230.257
Total Documents

Evolution of the number of published documents. All types of documents are considered, including citable and non citable documents.

YearDocuments
201652
201740
201839
201936
202043
202141
202218
20233
Citations per document

This indicator counts the number of citations received by documents from a journal and divides them by the total number of documents published in that journal. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric.

Cites per documentYearValue
Cites / Doc. (4 years)20160.000
Cites / Doc. (4 years)20171.096
Cites / Doc. (4 years)20181.250
Cites / Doc. (4 years)20191.565
Cites / Doc. (4 years)20201.413
Cites / Doc. (4 years)20211.525
Cites / Doc. (4 years)20221.428
Cites / Doc. (4 years)20231.065
Cites / Doc. (3 years)20160.000
Cites / Doc. (3 years)20171.096
Cites / Doc. (3 years)20181.250
Cites / Doc. (3 years)20191.565
Cites / Doc. (3 years)20201.313
Cites / Doc. (3 years)20211.441
Cites / Doc. (3 years)20221.442
Cites / Doc. (3 years)20230.902
Cites / Doc. (2 years)20160.000
Cites / Doc. (2 years)20171.096
Cites / Doc. (2 years)20181.250
Cites / Doc. (2 years)20191.354
Cites / Doc. (2 years)20201.387
Cites / Doc. (2 years)20211.481
Cites / Doc. (2 years)20221.036
Cites / Doc. (2 years)20230.898
Total Cites 
Self-Cites

Evolution of the total number of citations and journal's self-citations received by a journal's published documents during the three previous years.
Journal Self-citation is defined as the number of citation from a journal citing article to articles published by the same journal.

CitesYearValue
Self Cites20160
Self Cites20172
Self Cites20184
Self Cites20193
Self Cites20204
Self Cites20214
Self Cites20220
Self Cites20230
Total Cites20160
Total Cites201757
Total Cites2018115
Total Cites2019205
Total Cites2020151
Total Cites2021170
Total Cites2022173
Total Cites202392
External Cites per Doc 
Cites per Doc

Evolution of the number of total citation per document and external citation per document (i.e. journal self-citations removed) received by a journal's published documents during the three previous years. External citations are calculated by subtracting the number of self-citations from the total number of citations received by the journal’s documents.

CitesYearValue
External Cites per document20160
External Cites per document20171.058
External Cites per document20181.207
External Cites per document20191.542
External Cites per document20201.278
External Cites per document20211.407
External Cites per document20221.442
External Cites per document20230.902
Cites per document20160.000
Cites per document20171.096
Cites per document20181.250
Cites per document20191.565
Cites per document20201.313
Cites per document20211.441
Cites per document20221.442
Cites per document20230.902
% International Collaboration

International Collaboration accounts for the articles that have been produced by researchers from several countries. The chart shows the ratio of a journal's documents signed by researchers from more than one country; that is including more than one country address.

YearInternational Collaboration
201617.31
201717.50
201820.51
201911.11
202023.26
202117.07
202222.22
20230.00
Citable documents 
Non-citable documents

Not every article in a journal is considered primary research and therefore "citable", this chart shows the ratio of a journal's articles including substantial research (research articles, conference papers and reviews) in three year windows vs. those documents other than research articles, reviews and conference papers.

DocumentsYearValue
Non-citable documents20160
Non-citable documents201711
Non-citable documents201817
Non-citable documents201928
Non-citable documents202024
Non-citable documents202126
Non-citable documents202226
Non-citable documents202323
Citable documents20160
Citable documents201741
Citable documents201875
Citable documents2019103
Citable documents202091
Citable documents202192
Citable documents202294
Citable documents202379
Cited documents 
Uncited documents

Ratio of a journal's items, grouped in three years windows, that have been cited at least once vs. those not cited during the following year.

DocumentsYearValue
Uncited documents20160
Uncited documents201726
Uncited documents201849
Uncited documents201967
Uncited documents202062
Uncited documents202158
Uncited documents202257
Uncited documents202357
Cited documents20160
Cited documents201726
Cited documents201843
Cited documents201964
Cited documents202053
Cited documents202160
Cited documents202263
Cited documents202345
Scimago Journal & Country Rank
Show this widget in your own website

Just copy the code below and paste within your html code:
SCImago Graphica
Explore, visually communicate and make sense of data with our new data visualization tool.
Metrics based on Scopus® data as of March 2024
Loading comments…

Leave a comment

* Required

* Required

* Required

* Required

The users of Scimago Journal & Country Rank have the possibility to dialogue through comments linked to a specific journal. The purpose is to have a forum in which general doubts about the processes of publication in the journal, experiences and other issues derived from the publication of papers are resolved. For topics on particular articles, maintain the dialogue through the usual channels with your editor.

Developed by:
Scimago Lab
Powered by:
Powered by scopus

Follow us on @ScimagoJR

Scimago Lab, Copyright 2007-2024. Data Source: Scopus®

Legal Notice

Privacy Policy